Sie sind hier: Startseite Termine Patient Partnering in Clinical Development
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.

Patient Partnering in Clinical Development

08.02.2019 15:58
How to best integrate patients into your strategies and operations in clinical development – Step II The second Patient Partnering in Clinical Development (PPCD) conference will take place on 19-20 March 2019 and will continue to explore the role of patients in clinical development.



19.03.2019 um 13:15 bis
20.03.2019 um 09:00




he conference is addressed to all Professionals working in Pharmaceutical and Biotechnology companies, Clinical Research Organizations, Academic Centres, Hospital Centres, and Clinical Technology companies with a strong interest in integrating patients into their strategies and operations in healthcare development.

Termin übernehmen

The consequences of the new GDPR that came into force in May 2018 are yet to be seen. 
This new positioning of patients and how the industry needs to adapt to it, given that patients are going to have a stronger say in how, what and why their data is collected and processed, will surely give the industry a further wake-up call. Not only would patients have rights to demand access to their data, but they would also have the decision power to have their data removed or cancelled from records.

Nowadays the engagement with patients is increasing, not limited to the pharmaceutical industry, but also from regulatory authorities such as the FDA, the European Medicines Agency and the National Institute for Health and Care Excellence, where they are invited to provide their perspectives and advice during the decision-making process.

As they are involved in all stages of the drug life cycle, more than ever we’ll have to involve patients as active stakeholders in drug development.

Speaker presentations and an interactive workshop will share thoughts on:

  • Real World Evidence
  • Regulatory aspects and compliance
  • Recruitment and retention solutions
  • Trial designs
  • Challenges and milestones
  • Success stories

Scientific Board:

Nancy Meyerson-HessAssociate Partner at admedicum Business for Patients
Raphaela SchnurbusClinical Solutions Director at OPIS

Weitere Informationen über diesen Termin…


Fortbildungen für Ärzte 18.07.2019 09:00 - 17:00 — Köln
Tender & Payercontracts in Europa - Modelle & Trends 19.07.2019 09:00 - 17:00 — Frankfurt
Werbeaussagen absichern & verteidigen 23.07.2019 09:00 - 17:00 — Frankfurt
Design Thinking: Krankenkassenkooperationen 2020 25.07.2019 - 27.07.2019 — Hamburg
Beratung durch G-BA & Zulassungsbehörden - national & europäisch 15.10.2019 09:00 - 17:00 — Bonn
Kommende Termine…